Data analytics engineering group DBT Labs closed a $222m series D round including several corporates while 4Paradigm has filed an IPO prospectus again after its earlier attempt expired.

Funding US-based analytics engineering technology developer DBT Labs has raked in $222m in series D funding at a $4.2bn valuation in a round featuring data analytics software groups Databricks and Snowflake as well as GV and Salesforce Ventures, vehicles for conglomerate Alphabet and enterprise software supplier Salesforce respectively. Investment firm Altimeter Capital Management led the round, which included Amplify Partners, Andreessen Horowitz, Sequoia, Coatue, Tiger Global, Iconiq Growth and GIC. China-based autonomous lorry technology developer Inceptio has raised $188m in a series B-plus round co-led by Legend Capital, the VC firm formed by conglomerate Legend Holdings, and Sequoia Capital China. Diversified conglomerate Chow Tai Fook Enterprises, local services platform Meituan, electric vehicle maker Nio’s subsidiary Nio Capital and home improvement service WZ Group also took part, as did investment and financial services firm Fidelity’s Eight Roads Ventures unit, Cedarlake Capital and Everbright Group’s Broad Vision Funds. The company had previously received $500m in total including a $270m series B round in August 2021. China-based nuclear fusion technology developer Energy Singularity has raised RMB400m ($63m) in its first external funding round co-led by Nio Capital, a fund run by EV maker Nio, and game publisher MiHo Yo. Sequoia Capital China and BlueRun Ventures also took part in the round. Germany-based mobile advertising technology developer AddApptr has received $60m from IT services firm Aonic Group. China-based small molecule drug developer GluBio Pharmaceutical has received $50m in series A funding featuring Lilly Asia Ventures, a vehicle for pharmaceutical firm Eli Lilly, and Legend Capital, a fund formed by conglomerate Legend Holdings. Hillhouse Capital’s GL Ventures unit, Qiming Venture Partners, E Fund, Kaitai Capital and K2VC also took part in the round, which took the company’s overall funding to $70m. Thyas, a Japan-based immune cell therapy developer spun out of Kyoto University, has secured ¥2.13bn ($18.5m) in series B funding from financial services and investment firm Fidelity’s Eight Roads Ventures Japan and F-Prime Capital Partners units as well as consulting and investment management group D3. UK-headquartered electric vehicle charging technology developer EV.energy has extended its series A funding to $12.8m, having closed a tranche led by venture capital firm ArcTern Ventures and backed by Future Energy Ventures, part of energy utility Eon, as well as Energy Impact Partners and unnamed returning backers. The company had completed an $8.8m series A first close in June 2021 also featuring Future Energy Ventures. Switch Media, the Japan-based operator of television commercial analytics service Smart, has raised an…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.